Wangxiao He
First Hospital of Lanzhou University(CN)Lanzhou University(CN)
Publications by Year
Research Areas
RNA Interference and Gene Delivery, Nanoplatforms for cancer theranostics, Advanced biosensing and bioanalysis techniques, Immunotherapy and Immune Responses, Chemical Synthesis and Analysis
Most-Cited Works
- → Chiral Protein Supraparticles for Tumor Suppression and Synergistic Immunotherapy: An Enabling Strategy for Bioactive Supramolecular Chirality Construction(2020)207 cited
- → Self-Assembled Peptide–Lanthanide Nanoclusters for Safe Tumor Therapy: Overcoming and Utilizing Biological Barriers to Peptide Drug Delivery(2018)132 cited
- → A nano-predator of pathological MDMX construct by clearable supramolecular gold(I)-thiol-peptide complexes achieves safe and potent anti-tumor activity(2021)96 cited
- → N-Terminal Acetylation Preserves α-Synuclein from Oligomerization by Blocking Intermolecular Hydrogen Bonds(2017)85 cited
- → Self‐Assembly of Therapeutic Peptide into Stimuli‐Responsive Clustered Nanohybrids for Cancer‐Targeted Therapy(2019)82 cited
- → ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma(2017)77 cited
- → Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis(2015)73 cited
- → Human Enteric α-Defensin 5 Promotes Shigella Infection by Enhancing Bacterial Adhesion and Invasion(2018)72 cited
- → Dithiocarbamate-inspired side chain stapling chemistry for peptide drug design(2018)71 cited
- → Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy(2018)71 cited